Breaking down GLP-1 patient engagement strategies, challenges
Description
As many patients decide whether to take glucagon-like peptide 1 agonists (or GLP-1s), providers face various new patient engagement challenges. What patient engagement strategies can providers pursue to achieve shared decision-making, even when their patients decide to take GLP-1 compounds? In this episode, we hear one local dietitian share her experience guiding patients through the decision to take GLP-1s and we'll also touch base with one of our senior staff members to get a more comprehensive perspective on patient engagement trends in this area.
Featuring: Kate, a local dietitian in the Boston area
Sara Heath, executive editor at Xtelligent Healthcare
In this episode, we'll cover
- One dietitian’s experience with patient engagement on the topic of GLP-1s and weight loss
- The need for robust care management in GLP-1 usage
- How to respond when patients want to take/are taking a GLP-1 compound
and more!
References
- Patient education tips for GLP-1, weight loss drug treatment
- Is care management missing from the GLP-1 drug discourse?
To learn more about patient engagement, check out our Patient Engagement site.
To learn more about GLP-1s, visit our Pharma Life Sciences site.
And to watch video clips from the conversation, subscribe to our YouTube channel, @HealthcareStrategies.
United States
